Cantor Equity Partners Inc(CEP)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CEP Cantor Equity Partners Inc

盘前交易 01-10 04:53:03 EST

10.32

+0.00

0.00%

最高10.32	最低10.32	成交量67.00
今开10.32	昨收10.32	日振幅0.00%
总市值1.32亿	流通市值9,701万	总股本1,280万
成交额697.63	换手率0.00%	流通股本940.00万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"CEP","market":"US","secType":"STK","nameCN":"Cantor Equity Partners Inc","latestPrice":10.32,"timestamp":1736370000000,"preClose":10.32,"halted":0,"volume":67,"delay":0,"floatShares":9400000,"shares":12800000,"eps":0.055276,"marketStatus":"盘前交易","change":0,"latestTime":"01-10 04:53:03 EST","open":10.32,"high":10.32,"low":10.32,"amount":697.630063,"amplitude":0,"askPrice":16.47,"askSize":100,"bidPrice":4.15,"bidSize":200,"shortable":3,"etf":0,"ttmEps":0.055276,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1736519400000},"marketStatusCode":1,"adr":0,"listingDate":1723521600000,"exchange":"NASDAQ","adjPreClose":10.32,"postHourTrading":{"tag":"盘后","latestPrice":10.36,"preClose":10.32,"latestTime":"16:00 EST","volume":2,"amount":20.72,"timestamp":1736370002480},"volumeRatio":0.025260140425117},"requestUrl":"/m/hq/s/CEP/tweets","defaultTab":"tweets","newsList":[{"id":"2488564717","title":"东亚药业(605177.SH)：头孢克洛原料药(酶法)获得欧洲CEP证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2488564717","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488564717?lang=zh_cn&edition=full","pubTime":"2024-12-02 15:31","pubTimestamp":1733124705,"startTime":"0","endTime":"0","summary":"智通财经APP讯，东亚药业(605177.SH)发布公告，公司全资子公司浙江东邦药业有限公司收到欧洲药品质量管理局(EDQM)签发的头孢克洛原料药(酶法)CEP证书(欧洲药典适用性证书)，头孢克洛为第二代头孢类抗菌药物，可用于治疗敏感菌引起的多种呼吸道感染、泌尿道感染、耳鼻科感染和皮肤及软组织感染等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1218851.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["605177","CEP","BK0239"],"gpt_icon":0},{"id":"2474051703","title":"国邦医药(605507.SH)全资子公司原料药获得CEP证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2474051703","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474051703?lang=zh_cn&edition=full","pubTime":"2024-10-11 15:56","pubTimestamp":1728633407,"startTime":"0","endTime":"0","summary":"国邦医药(605507.SH)公告，近日，公司全资子公司山东国邦药业有限公司(简称...","market":"us","thumbnail":"https://img.zhitongcaijing.com/astock/12.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/astock/12.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1192794.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK0239","CEP","605507"],"gpt_icon":0},{"id":"2468126547","title":"美诺华(603538.SH)：阿托伐他汀钙原料药获得欧洲CEP证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2468126547","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468126547?lang=zh_cn&edition=full","pubTime":"2024-09-19 16:25","pubTimestamp":1726734331,"startTime":"0","endTime":"0","summary":"智通财经APP讯，美诺华(603538.SH)发布公告，近日，公司收到欧洲药品质量管理局(简称“EDQM”)签发的关于阿托伐他汀钙(原料药)的欧洲CEP证书(欧洲药典适用性证书)。药品适应症：适用于高胆固醇血症原发性高胆固醇血症患者。阿托伐他汀钙(原料药)作为公司的重点产品之一，本次该药品顺利获得CEP证书，显示了欧洲规范市场对该原料药的工艺及质量的认可，体现了公司优秀的工艺研发和质量管控能力。为公司进一步拓展国际市场，提供了竞争基础和优势。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1184569.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["CEP","603538","BK0239"],"gpt_icon":0},{"id":"2467983721","title":"润都股份(002923.SZ)：氯沙坦钾原料药获得CEP证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2467983721","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467983721?lang=zh_cn&edition=full","pubTime":"2024-09-13 20:05","pubTimestamp":1726229109,"startTime":"0","endTime":"0","summary":"智通财经APP讯，润都股份(002923.SZ)发布公告，公司近日收到欧洲药品质量管理局(“EDQM”)签发的关于氯沙坦钾原料药欧洲药典适用性证书(Certificate of Suitability to Monograph of European Pharmacopoeia，以下简称“CEP证书”)。本品获得CEP证书，标志着欧洲规范市场和其他认可CEP证书的市场对该原料药工艺及质量的认可，为公司进一步拓展国际市场，提供了竞争优势。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1183279.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","002923","CEP"],"gpt_icon":0},{"id":"2464932801","title":"翰宇药业：生长抑素原料药获CEP证书 有利于海外市场拓展","url":"https://stock-news.laohu8.com/highlight/detail?id=2464932801","media":"中国财富通","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464932801?lang=zh_cn&edition=full","pubTime":"2024-09-04 16:43","pubTimestamp":1725439436,"startTime":"0","endTime":"0","summary":"中国财富通9月4日 - 翰宇药业（300199）公告称，近日，公司的生长抑素原料药收到欧洲药品质量管理局签发的CEP证书（原料药欧洲药典适用性证书），本次生长抑素获得欧洲药品质量管理局签发的CEP证书，为公司的生长抑素原料药进入欧盟市场开拓了准入通道，有利于公司原料药海外市场的拓展，未来将对公司经营业绩产生积极影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://irb.cfbond.com/api/v1/detail.html?newsid=3MJLEKqZ8b0%3D","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0070","BK0239","300199","BK0028","CEP","BK0077","BK0188"],"gpt_icon":0},{"id":"2464914340","title":"翰宇药业(300199.SZ)：生长抑素原料药获得CEP证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2464914340","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464914340?lang=zh_cn&edition=full","pubTime":"2024-09-04 16:29","pubTimestamp":1725438545,"startTime":"0","endTime":"0","summary":"智通财经APP讯，翰宇药业(300199.SZ)发布公告，近日，公司的生长抑素原料药收到欧洲药品质量管理局(以下简称“EDQM”)签发的CEP证书(原料药欧洲药典适用性证书)。生长抑素是人工合成的环状十四氨基酸肽，其与天然生长抑素在化学结构和作用机理上完全相同。生理性生长抑素主要存在于丘脑下部和胃肠道。本次生长抑素获得欧洲药品质量管理局签发的CEP证书，为公司的生长抑素原料药进入欧盟市场开拓了准入通道，有利于公司原料药海外市场的拓展，未来将对公司经营业绩产生积极影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1179182.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK0188","BK0070","CEP","BK0028","300199","BK0077"],"gpt_icon":0}],"profile":{"websiteUrl":"http://","stockEarnings":[{"period":"1week","weight":-0.0067},{"period":"1month","weight":0.0068},{"period":"3month","weight":0.0289},{"period":"6month","weight":0.032},{"period":"ytd","weight":-0.0067}],"compareEarnings":[{"period":"1week","weight":0.0058},{"period":"1month","weight":-0.0251},{"period":"3month","weight":0.0232},{"period":"6month","weight":0.0527},{"period":"1year","weight":0.244},{"period":"ytd","weight":0.0058}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cantor Equity Partners, Inc.是一家空白支票公司，于2020年11月11日作为开曼群岛豁免公司注册成立，目的是与一家或多家企业进行合并、股份交换、资产收购、股份购买、重组或类似业务合并。","exchange":"NASDAQ","name":"Cantor Equity Partners Inc","nameEN":"Cantor Equity Partners Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.30.0","shortVersion":"4.30.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cantor Equity Partners Inc(CEP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Cantor Equity Partners Inc(CEP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Cantor Equity Partners Inc,CEP,Cantor Equity Partners Inc股票,Cantor Equity Partners Inc股票老虎,Cantor Equity Partners Inc股票老虎国际,Cantor Equity Partners Inc行情,Cantor Equity Partners Inc股票行情,Cantor Equity Partners Inc股价,Cantor Equity Partners Inc股市,Cantor Equity Partners Inc股票价格,Cantor Equity Partners Inc股票交易,Cantor Equity Partners Inc股票购买,Cantor Equity Partners Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cantor Equity Partners Inc(CEP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Cantor Equity Partners Inc(CEP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}